Patient-activated transvenous cardiac stimulation for the treatment of supraventricular and ventricular tachycardia

Geoffrey O. Hartzler, David Holmes, Michael J. Osborn

Research output: Contribution to journalArticle

22 Scopus citations

Abstract

Recurrent, drug-refractory sustained tachycardias present a difficult management problem. After invasive electrophysiologic study and extensive antiarrhythmic drug testing, a permanent transvenous lead system and radiofrequency stimulator that required patient activation for burst pacing were implanted in eight patients with refractory Supraventricular tachycardia and in nine patients with refractory ventricular tachycardia. In a follow-up period of 2 to 28.5 months (mean 12) each patient has successfully terminated multiple episodes of recurrent tachycardia without complicatlon. This therapeutic approach has allowed a reduction in antiarrhythmic drug dosage and adverse effects, has obviated the need for frequent hospital admissions resulting from recurrent tachycardia, and has met with excellent patient acceptance.

Original languageEnglish (US)
Pages (from-to)903-909
Number of pages7
JournalThe American journal of cardiology
Volume47
Issue number4
DOIs
StatePublished - Jan 1 1981

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Patient-activated transvenous cardiac stimulation for the treatment of supraventricular and ventricular tachycardia'. Together they form a unique fingerprint.

  • Cite this